Correlation Engine 2.0
Clear Search sequence regions

In this study, the in vitro antitumor activity of chenodeoxycholic acid-verticinone ester (CDCA-Ver), a novel compound and its underlying mechanisms were evaluated. Results showed that CDCA-Ver significantly inhibited HepG2 cell viability in a both dose- and time-dependent manner, moreover CDCA-Ver induced apoptotic cell death and G(0)/G(1) cell cycle arrest in HepG2 cells. ROS generation, loss of balance of Bax/Bcl-2 ratio, loss of mitochondrial transmembrane potential, activation of caspases and elevation of intracellular free Ca(2+) concentration were involved in the CDCA-Ver induced apoptosis pathway in HepG2 cells. We concluded that CDCA-Ver may be a potential candidate for the therapy of cancer. Copyright © 2012 Elsevier Inc. All rights reserved.


Dong Liang, Qing Zhou, Jiuliang Zhang, Wei Gong, Chuanrui Xu, Bin Li, Yi Wang, Jiangtao Li. A novel chenodeoxycholic acid-verticinone ester induces apoptosis and cell cycle arrest in HepG2 cells. Steroids. 2012 Nov;77(13):1381-90

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 22974827

View Full Text